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Cystic fibrosis (CF) is the most common genetic disorder that causes a significant
damage in secretory epithelial cells due to the defective ion flux across the cystic fibrosis
transmembrane conductance regulator (CFTR) Cl− channel. Pancreas is one of the
organs most frequently damaged by the disease leading to pancreatic insufficiency,
abdominal pain and an increased risk of acute pancreatitis in CF patients causing a
significant decrease in the quality of life. CFTR plays a central role in the pancreatic ductal
secretory functions by carrying Cl− and HCO3− ions across the apical membrane.
Therefore pathophysiological studies in CF mostly focused on the effects of impaired ion
secretion by pancreatic ductal epithelial cells leading to exocrine pancreatic damage.
However, several studies indicated that CFTR has a central role in the regulation of
intracellular signaling processes and is now more widely considered as a signaling hub
in epithelial cells. In contrast, elevated intracellular Ca2+ level was observed in the lack
of functional CFTR in different cell types including airway epithelial cells. In addition,
impaired CFTR expression has been correlated with damaged mitochondrial function in
epithelial cells. These alterations of intracellular signaling in CF are not well characterized
in the exocrine pancreas yet. Therefore in this review we would like to summarize the
complex role of CFTR in the exocrine pancreas with a special focus on the intracellular
signaling and mitochondrial function.
Keywords: cystic fibrosis transmembrane conductance regulator, epithelial cells, Ca signaling, mitochondrial
damage, cystic fibrosis, exocrine pancreas
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE
REGULATOR AND ITS ROLE IN PANCREATIC PHYSIOLOGY
Since its discovery in 1989 (Kerem et al., 1989; Riordan et al., 1989) cystic fibrosis transmembrane
conductance regulator (CFTR) has been one of the most widely investigated proteins, presumably
due to its central role in the common genetic disorder cystic fibrosis (CF). CFTR is localized in
the apical plasma membrane of secretory epithelia mediating anion (Cl− and HCO3−) eﬄux to
the lumen. This protein consists of five domains: two transmembrane domains, two cytoplasmic
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nucleotide-binding domains (NBD) and a regulatory (R) domain
[interested readers can find detailed reviews about the structure
and the structure- function relationships of CFTR in recent
publications (Liu et al., 2017; Callebaut et al., 2018)]. In non-
stimulated cells the unphosphorylated R domain binds to NBD1
preventing the interaction of NBD1 with NBD2 and thus ATP
hydrolysis, which is mandatory for the opening of the channel.
During physiological stimulation agonist binding to adenylyl
cyclase (AC) coupled receptors increases the intracellular
cAMP and activate protein kinase A (PKA). Active PKA can
phosphorylate the R domain resulting in its dissociation from
NBD1 and allowing the interaction of NBD1 and NBD2. The
released R domain forms connection between CFTR and other
membrane proteins and transporters (Sheppard and Welsh, 1999;
Guggino and Stanton, 2006a). One example of such a connection
is the interaction of CFTR with the SLC26A6 Cl−/HCO3−
exchanger. The STAS domain of SLC26A6 interacts with the
phosphorylated R domain of CFTR leading to the simultaneous
activation of the two membrane proteins (Hong et al., 2014).
Other CFTR domains mediate protein-protein interactions and
stabilize CFTR in the apical membrane. These domains include
postsynaptic density-95/disc-large/zonula occludens-1 (PDZ)-
interacting domains, a protein phosphatase-2A-binding domain,
AMP kinase-binding domain in the C terminus and syntaxin-
1A-binding domain and synaptosome-associated protein binding
domain in the N-terminus (Shenolikar et al., 2004; Brone and
Eggermont, 2005; Guggino and Stanton, 2006a,b).
Cystic fibrosis transmembrane conductance regulator is found
in several functionally different organs and tissues including
lung, salivary glands, esophagus, stomach, biliary tract, sweat
duct, intestine, kidney, heart, vas deferens and pancreas playing
a fundamental role in the physiological secretory processes
(Bradbury, 1999). Within the gastrointestinal tract CFTR
expression varies among different tissues. In the gastric mucosa
CFTR expression is lower (Strong et al., 1994) in contrast to
the apical membrane of cholangiocytes (Strong et al., 1994), or
small intercalated and proximal intralobular pancreatic ductal
epithelial cells where high expression of CFTR can be detected
(Marino et al., 1991). The levels of expression correlate with
the significance of CFTR function. As an example CF is
commonly complicated by exocrine pancreatic insufficiency
suggesting the importance of CFTR function in pancreas
physiology.
Cystic fibrosis transmembrane conductance regulator plays a
fundamental role in the production of the alkaline, isotonic fluid
secreted by pancreatic ductal cells in response to food intake that
may contain up to 140 mM HCO3−. The physiological function
of this alkaline secretion is to wash out the secreted digestive
proenzymes from the pancreatic ductal tree into the duodenum
and to neutralize acidic chyme entering the proximal part of
the small intestine. Additionally, the alkaline fluid neutralizes
the protons co-released during digestive enzyme secretion by
pancreatic acinar cells (Behrendorff et al., 2010). However, a
recent publication by Han et al. (2016) suggests that pancreatic
acinar cells might be capable of HCO3− secretion as well.
Acinar cells express the Ca2+ activated Cl− channel Anoctamin1
(ANO1) – but not CFTR – on the apical membrane, which
channel’s anion selectivity can be dynamically modulated by
the Ca2+/calmodulin complex making it permeable for HCO3−
(Jung et al., 2013). On the other hand the vital role of ductal
secretion in the pancreatic physiology is supported by several
observations. Impaired ductal secretion in CFTR knockout
mice alters the membrane dynamics and endocytosis at the
apical plasma membrane of pancreatic acinar cells (Freedman
et al., 2001). In addition decreased ductal secretion in Na+/H+
exchanger regulatory factor-1 (NHERF1) knockout mice, due to
the loss of CFTR leads to more severe experimental AP (Pallagi
et al., 2014). More importantly pharmacological restoration
of CFTR function in pancreatic ducts corrected acinar cell
function and decreased pancreatic inflammation (Zeng et al.,
2017). As the autoactivation of trypsinogen is a pH dependent
process, which is accelerated in acidic pH ranges, the alkaline
intraductal pH prevents the premature trypsinogen activation
and thus protecting the pancreas from autodigestion (Pallagi
et al., 2011).
In the recent years it became very clear that HCO3− eﬄux
trough CFTR has a central role in the ductal secretion, which is
the result of a strictly regulated interaction of the electrogenic
SLC26A6 Cl−/HCO3− exchanger and the CFTR Cl− channel
(Lee et al., 2012; Maleth and Hegyi, 2014) (Figure 1). Due to this
interaction (between STAS and R domains, see above) the ductal
cells are able to establish 140 mM maximal intraluminal HCO3−
concentration, which is ∼5–6 fold higher than the intracellular
(Hong et al., 2014). The luminal Cl− concentration is another
factor in the coordination of CFTR permeability. According to
the current model, in the proximal ducts the intraluminal Cl−
concentration is above 30 mM therefore in this case CFTR
provides the extracellular substrate for the Cl−/HCO3− exchange
of SLC26A6. At the distal part of the pancreatic ductal tree
the luminal and intracellular Cl− concentration drops thus the
anion exchange of SLC26A6 is insufficient. The low intracellular
Cl− activates the With-No-Lysine (WNK)/STE20/SPS1-related
proline/alanine-rich kinase (SPAK) kinase pathway switching
CFTR permeability in favor of HCO3− (Park et al., 2010).
The exact molecular mechanisms and regulation of pancreatic
ductal secretion have been recently reviewed in details (Lee
et al., 2012). Importantly, mutations in CFTR responsible for
chronic pancreatitis (CP), but not CF were found to selectively
modify the HCO3− permeability of CFTR (LaRusch et al., 2014).
The mutations identified in this study were associated with
pancreatitis, but did not cause an ordinary CF phenotype. In a
subsequent analysis, the authors concluded that these mutations
cause the loss of WNK1/SPAK pathway-activated increase in
the HCO3− permeability of CFTR. Notably, since the Cl−
permeability is not affected, these mutations only damage the
pancreas.
ROLE OF Ca2+ SIGNALING IN THE
REGULATION OF CFTR
In the traditional view CFTR is a cAMP activated Cl− channel as
described above, however, in the recent years significant number
of studies have highlighted the importance of Ca2+ signaling
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FIGURE 1 | Mechanism of pancreatic ductal HCO3− secretion. Pancreatic ductal cells secrete HCO3− rich isotonic fluid as a result of a complex interplay by several
transport proteins. HCO3− is accumulated across the basolateral membrane Na+/HCO3− cotransporter NBCe1-B. Via the luminal membrane HCO3− is secreted
by SLC26A6 and likely A3 Cl−/HCO3− exchangers and cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel. The operation of these
transporters allows the pancreatic ductal cells to create 140 mM maximal bicarbonate concentration during stimulated secretion. The CFTR R domain and the STAS
domain of the SLC26 Cl−/HCO3− exchangers interact increasing the overall open probability of CFTR. At the beginning of the ductal system in the proximal ducts
the intraluminal Cl− concentration is high, and thus HCO3− is secreted via Cl−/HCO3− exchange regulated by IRBIT. In the distal part the intraluminal Cl− drops and
the low intracellular Cl− concentration activates the WNK/SPAK kineses, which phosphorylate CFTR, switching the ion selectivity to HCO3−.
and the synergism between Ca2+ and cAMP signalization in
the regulation of pancreatic epithelial functions (Ahuja et al.,
2014) (Figure 2). Activation of CFTR by Ca2+ have been
suggested earlier by Namkung et al. (2003). Using Capan-1, a
pancreas adenocarcinoma cell line, which express endogenous
CFTR, they showed that Ca2+ signals activate the Cl− dependent
HCO3− transport of CFTR. This effect was completely absent in
CFPAC-1 cells, which shows no CFTR expression, but adenovirus
mediated overexpression of CFTR restored the stimulation. Using
other models Seidler et al. (1997) found that in rodent small
intestine a functional CFTR protein is required for cAMP-; cGMP
and Ca2+ dependent HCO3− secretion. They showed that 75–
100% reduction of carbachol-stimulated HCO3− secretion can be
observed in Cftr knockout mice compared to wild type animals.
Whereas inhibition of CFTR with CFTRinh-172 diminished the
responses to cholinergic agonists in pig submucosal glands
(Thiagarajah et al., 2004). In addition, pilocarpine, a Ca2+-
mobilizing muscarinic agonist that is widely used in sweat Cl−
tests to measure CFTR activity, most likely affect CFTR through
Ca2+ (Joo et al., 2010; Sun et al., 2010; Cho et al., 2011; Maleth
et al., 2015a).
Another well-known fact is that the increase of intracellular
Ca2+ influences the activity of different AC isoforms. The ACs
inhibited by intracellular Ca2+/PKC/PKA are AC5 and AC6
while AC1, AC3 and AC8 are Ca2+/Calmodulin stimulated
(Halls and Cooper, 2011; Willoughby, 2012). In a recent study
Sabbatini et al. (2013) reported that AC3, AC4, AC6, AC7,
and AC9 are expressed in the pancreatic ductal epithelia. The
authors demonstrated that isolated ducts from AC6 knockout
mice represented reduced cAMP generation, PKA activation
and ductal fluid secretion. These results suggest that AC6
is important in the regulation of pancreatic fluid secretion
in response to hormonal stimulation (such as secretin and
VIP). The findings of this study raise interesting questions
how synergy between Ca2+ and cAMP signaling is executed
(since AC6 is inhibited by Ca2+). In a recent publication Park
et al. (2013) suggested that inositol 1,4,5-triphosphate (InsP3)
receptor-binding protein released with InsP3 (IRBIT) controls
the synergy between the Ca2+ and cAMP signaling pathways. The
authors demonstrated that co-expression of CFTR and SLC26A6
with IRBIT maximally activate the two proteins in response to
low agonist concentration, whereas IRBIT knockdown reduced
their activation. PKA activation with forskolin left shifted
the concentration-dependence of SLC26A6 activation by Ca2+
without directly activating SLC26A6. In contrast, Ca2+ signaling
evoked by carbachol enhanced activation of CFTR by cAMP.
The synergy was mediated by intracellular release of IP3 rather
than Ca2+ since the synergism by IRBIT was independent of
cytoplasmic Ca2+.
Another interesting aspect of CFTR regulation is that different
AC isoforms are localized in different nanodomains of the plasma
membrane. The Ca2+ regulated AC1, AC5, AC6, and AC8 are
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FIGURE 2 | Regulation of CFTR by the intracellular Ca2+. Although CFTR is mainly considered as a cAMP regulated ion channel, several observations suggest that
the intracellular Ca2+ can regulate CFTR activity by a complex mechanism. First of all, Ca2+ can increase the activity of several adenylyl cyclase (AC) isoform
increasing the production of cAMP. In another suggested pathway Ca2+ activates CFTR, at least in part, through activation of the Pyk2/Src complex and tyrosine
phosphorylation. Very recently Bozoky et al. showed that CFTR and calmodulin colocalize at the apical membrane of primary cells and that calmodulin interacts
directly with the R domain of CFTR in a Ca2+- and phosphorylation-dependent manner. This interaction triggered an open probability of CFTR, which was similar to
that due to PKA phosphorylation.
targeted into lipid rafts in the plasma membrane, whereas the
Ca2+ independent AC2 and AC7 are excluded from these rafts
(Delint-Ramirez et al., 2011; Ahuja et al., 2014). This integrated
subcellular localization could potentially promote the regulation
of AC activity and thus intracellular cAMP levels through Ca2+.
Supporting this idea in 2013 Namkung et al. (2010) have reported
the regulation of CFTR by AC1. They suggested that CFTR in
primary cultures of human bronchial epithelial cells is regulated
by intracellular Ca2+ that activates AC1 and the downstream
cAMP/PKA signaling. They have also found the colocalization
of the two in the apical membrane of the cells suggesting that
AC1-CFTR interaction is an important part of the cross-talk
between the Ca2+ and cAMP signaling. A more recent study
confirmed these finding by showing that α7 nAChR plays an
important role in the regulation of CFTR function and in the
pathogenesis of smoking-related chronic lung diseases (Maouche
et al., 2013). The authors demonstrated that Ca2+ entry trough
α7 nAChR activates AC1 and PKA, which in turn leads to CFTR
activation. They found that α7 nAChR, CFTR, and AC1 are
associated in supramolecular complexes within lipid rafts at the
apical membrane of airway epithelial cells.
Billet et al. (2013) investigated in details how carbachol-
induced elevation of cAMP increases CFTR activity. Using
BHK cells that co-express CFTR and muscarinic acetylcholine
receptor (M3R) they found that only ∼50% of the cholinergic
response was evoked by Ca2+ induced activation of ACs;
whereas after PKA inhibition, or removal of 15 PKA consensus
sequences of CFTR, almost half of the CFTR response persisted.
In further analysis the authors showed that Src Inhibitor-
1 (Inh-1) (which inhibits Src tyrosine kinase) abolished the
PKA-independent component of muscarinic stimulation. Based
on their results the authors proposed that Ca2+ activates
CFTR, at least in part, through activation of the Pyk2/Src
complex and tyrosine phosphorylation. Another interesting
aspect of PKA-independent activation of CFTR by Ca2+ elevation
was recently reported by Bozoky et al. (2017). The authors
showed that CFTR and calmodulin colocalize at the apical
membrane of primary cells and that calmodulin interacts
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directly with the R domain of CFTR in a Ca2+-, and
phosphorylation-dependent manner. This interaction triggered
an open probability of CFTR, which was similar to that induced
by PKA phosphorylation.
ABSENCE OF CFTR ALTERS Ca2+
HOMEOSTASIS
Cystic fibrosis transmembrane conductance regulator is a plasma
membrane ion channel that extensively contributes to the
epithelial ion and fluid secretion. Therefore it is not surprising
that most research studies in CF focus on the effect of CFTR
damage to the whole organ. However, CFTR has a complex
integrative role in the intracellular signaling therefore it could
be considered as a central signaling hub. Taken this into
consideration we can presume that in cells with aberrant CFTR
expression the intracellular signaling processes are influenced as
well. Indeed, early studies in the 80s by Shapiro et al. highlighted
that the intracellular Ca2+ concentration is elevated in different
cell types (fibroblasts and lymphocytes) both from homozygous
or heterozygous carriers as demonstrated by atomic absorption
spectrophotometry (Feigal and Shapiro, 1979a; Shapiro and Lam,
1982, 1987). Moreover they demonstrated that the mitochondrial
Ca2+ uptake is significantly increased in CF fibroblasts (Feigal
and Shapiro, 1979b). By that time CFTR was not discovered and
these observations suggested that CF might be caused by altered
Ca2+ homeostasis and could be a mitochondria related disorder.
This theory was eventually abolished by the identification of
CFTR and reasonably, research interest was focused on its
channel properties. However, the alterations of intracellular Ca2+
are still present, but shall be considered as consequences of the
impaired CFTR function, or expression and not the cause of
CF. More recent studies provided deeper understanding of the
development of altered intracellular Ca2+ levels (Figure 3). As
an underlying mechanism for altered Ca2+ signaling, increased
IP3R-dependent Ca2+ response has been suggested in F508del-
CFTR expressing airway epithelial cells, which was normalized
following the correction of the abnormal trafficking of F508del-
CFTR (Antigny et al., 2008b). Whereas Philippe et al. (2015)
showed that both sarco/endoplasmic reticulum Ca2+-ATPase
(SERCA) and plasma membrane Ca2+-ATPase (PMCA) pumps
can contribute to the deregulation of the Ca2+ homeostasis in CF.
The activity of the SERCA pump and the ER Ca2+ concentration
FIGURE 3 | Intracellular changes in cystic fibrosis. Impaired expression of CFTR causes the condensation of the ER network due to the trapped CFTR protein in the
ER lumen. This morphological change will result in IP3R clustering and increased IP3R activity complicated with increased SERCA, TRPC6, and Orai1 activity in the
ER and plasma membrane, respectively. Importantly, the PMCA activity is impaired leading to sustained intracellular Ca2+ elevation. The intracellular Ca2+ overload
promotes mitochondrial damage through increased mitochondrial Ca2+ uptake. These changes together will lead to further decrease of the epithelial ion secretion
that could significantly damage the exocrine pancreas.
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were strongly increased, while PMCA function is significantly
impaired in CF bronchial epithelial cells. They also confirmed
the earlier findings on the elevated mitochondrial Ca2+ uptake in
CF cells compared to controls. Treatment with the CFTR folding
corrector VX-809 reversed the alterations of the intracellular
Ca2+ signaling. Interestingly, they demonstrated the physical
interaction of SERCA2b with CFTR, and PMCA with CFTR.
Antigny et al. (2008a) have also found that once F508del CFTR
was rescued by miglustat or low temperature in human CF-
KM4 cells Ca2+mobilization decreased compared to uncorrected
cells. In another study the contribution of transient receptor
potential canonical 6 (TRPC6) channel has been demonstrated
to the increased intracellular Ca2+ levels. This study showed that
CFTR and TRPC6 are functionally coupled within a molecular
complex in airway epithelial cells, which is lost in CF leading to
abnormally increased TRPC6-dependent Ca2+ influx (Antigny
et al., 2011b). Balghi et al. (2011) found elevated extracellular
Ca2+ entry in CFBE cells due to enhanced Orai1 insertion
into the plasma membrane in CF leading to increased IL-8
secretion, which is a major contributor to the inflammation in
CF. Thus, in the proposed model the F508del-CFTR mutation
caused the condensation of the ER network due to the trapped
CFTR protein in the ER. This morphological change will result
in IP3R clustering and increased IP3R activity complicated with
increased SERCA, TRPC6 and Orai1 activity in the ER and
plasma membrane, respectively. In addition, the PMCA activity
seems to be impaired (Antigny et al., 2011a). These together
lead to increased ER Ca2+ concentration, which might further
impair the folding of CFTR since decreasing and also maintaining
low ER Ca2+ level promotes the correction of defective F508del-
CFTR (Norez et al., 2006).
ALTERED MITOCHONDRIAL FUNCTION
IN CF
The intracellular Ca2+ signaling regulates mitochondrial
function via mitochondrial Ca2+ uptake, which enhances the
activity of tricarboxylic acid cycle dehydrogenases and the ATP
synthase (Hansford and Zorov, 1998). Under physiological
conditions the mitochondrial Ca2+ levels are tightly controlled
by the mitochondrial Ca2+ uniporter (MCU) responsible for
Ca2+ uptake (Baughman et al., 2011; De Stefani et al., 2011)
and Na+/Ca2+ exchanger (NCLX) (Palty et al., 2010) for
the eﬄux. Moreover in several cell types mitochondria act
as Ca2+ buffers that help to prevent sustained global raises
of intracellular Ca2+. However, sustained excess of cytosolic
Ca2+, as seen in CF, can lead to mitochondrial Ca2+ overload
and injury that ultimately activate apoptosis or necrosis. In
addition, mitochondrial Ca2+ can induce the mitochondrial
permeability transition pore (MPTP) opening that results in the
loss of mitochondrial membrane potential, uncoupling of the
respiratory chain and a consequent drop of mitochondrial ATP
synthesis. The increased permeability of the inner mitochondrial
membrane eventually leads to mitochondrial swelling, rupture,
and necrotic cell death (Golstein and Kroemer, 2007; Halestrap,
2009). The investigation of mitochondrial dysfunction in CF –
similarly to altered cytosolic Ca2+ handling – goes back to the
70s. In an early study Antonowicz et al. (1972) demonstrated
an increased activity of the lysosomal α-glucosidase but did
not find any defect in three of the mitochondrial enzymes
tested (succinic dehydrogenase, glutamic dehydrogenase, and
malic dehydrogenase). Few years later Feigal and Shapiro
described increased mitochondrial Ca2+ uptake, mitochondrial
oxygen consumption in mitochondria isolated from CF
skin fibroblasts (Feigal and Shapiro, 1979b) and increased
mitochondrial energy expenditure (Shapiro, 1988). Similarly,
impaired Ca2+ handling, mitochondrial damage emerged as a
consequence of CFTR mutations and not the cause of CF. More
recently Antigny et al. (2009) showed that the mitochondrial
network is fragmented in F508del-CFTR expressing airway
epithelial cells, the 19m is depolarized and Ca2+ uptake is
reduced in CF mitochondria compared to control cells not
effected by CF. They proposed that the deficient mitochondrial
Ca2+ uptake is a consequence of mitochondrial membrane
depolarization. Another study of F508del airway cells described
impaired mitochondrial oxygen consumption, mitochondrial
membrane potential, adenine nucleotide translocator-dependent
ADP/ATP exchange and mitochondrial Complex I and IV
activities, whereas both mitochondrial ROS production and
membrane lipid peroxidation were increased (Atlante et al.,
2016). The authors demonstrated that VX-809 treatment
significantly improved all the parameters. On the other hand,
the expression of MT-ND4, which is a mitochondrial gene
encoding a subunit of the mitochondrial Complex I, seems
to be CFTR-dependent. The gene expression is decreased if
CFTR expression, or activity is impaired (Valdivieso et al.,
2007), which in turn reduce the activity of mitochondrial
Complex I (Valdivieso et al., 2012). As a consequence of these
changes, Rimessi et al. (2015) demonstrated that the degree
and quality of the inflammatory response in CF are supported
by mitochondrial perturbation, which was dependent on
the presence of Pseudomonas aeruginosa infection. In this
process flagellin protein acted as the inducer of mitochondrial
dysfunction leading to MCU mediated mitochondrial Ca2+
overload, which in turn leads to inflammasome NLRP3
activation, IL-1β and IL-18 processing (Rimessi et al., 2015).
In accord with the mitochondrial dysfunction, several work
described increased apoptotic cell death in CF (Valdivieso
and Santa-Coloma, 2013). As the underlying mechanism
some studies suggest that the increased apoptosis is a result
of recurrent bacterial infections (Jendrossek et al., 2003;
Kirschnek and Gulbins, 2006), while others proposed that it
is a primary consequence of CF that occurs without infection
(I’Hoste et al., 2010; Rottner et al., 2011). The alterations
include enhanced ROS production, release of cytochrome c
mitochondrial depolarization and also the activation of c-Jun
N-terminal kinases (JNKs) (Jendrossek et al., 2003). Other
studies highlight that increased apoptosis might be due to the
impaired oxidant-antioxidant balance, which may contribute
to the inflammation in CF [reviewed recently in I’Hoste et al.
(2010), Rottner et al. (2011), and Ziady and Hansen (2014)].
Rottner et al. (2007) have also linked the NF-κB pathway to the
initiation of apoptosis.
Frontiers in Physiology | www.frontiersin.org 6 December 2018 | Volume 9 | Article 1585
fphys-09-01585 December 19, 2018 Time: 16:52 # 7
Madácsy et al. Intracellular Damage in Cystic Fibrosis
THE ROLE OF CFTR IN PANCREATIC
DISEASE PATHOGENESIS
Cystic Fibrosis
Cystic fibrosis is the most common autosomal recessive genetic
disease characterized by multiorgan pathology and significantly
decreased life expectancy caused by the impaired function or
expression of CFTR. Due to recent therapeutic developments,
the life expectancy of patients with CF elevated significantly in
the past decades, however, the average age of death (usually
caused by respiratory failure) is still 31.4 years (Annalisa Orenti
et al., 2016). In addition, 31% of the CF patients have a chronic
lung infection caused by P. aeruginosa, whereas 83% of all CF
patients are in need of pancreatic enzyme replacement therapy
causing a significant burden to the patients and to the healthcare
systems.
Currently more than 2000 CFTR gene mutations have been
described, whereas only 159 mutations have been characterized
in terms of disease liability (Sosnay et al., 2013; De Boeck
and Amaral, 2016; Bolia et al., 2018). The most common
mutation type in 85% of patients worldwide is the deletion of
phenylalanine at position 508 (F508del), which was identified
by Riordan et al. (1989). To date mutations are classified
into seven different groups according to the CFTR defect
caused (De Boeck and Amaral, 2016; Hegyi et al., 2016):
Class I mutations, which include frame shift, splicing or
non-sense mutations that introduce premature termination
codons; Class II mutations, which lead to misfolding and
impaired protein biogenesis at the ER; Class V mutations
which result in reduced synthesis due to promoter or splicing
abnormalities; and Class VI mutations that destabilize the
channel in post-ER compartments and/or at the PM. Whereas
Class III and IV mutations impair the gating and channel
pore conductance, respectively, thus selectively compromising
CFTR function. In case of Class VII mutations no messenger
RNA can be detected. The disease affects all CFTR expressing
epithelia, but pancreas is one of the organs that’s harmed
the earliest and damaged most severely by CF (Wilschanski
and Novak, 2013). Apparently the lack of CFTR has a
dramatic impact on the exocrine pancreatic secretion due to
its central role in this process (see above). Pancreatic damage
results in severe inflammation, secretion of viscous, protein
rich fluid leading to obstruction of ducts by mucoprotein
plugs, calcification, the destruction of acini, pancreatic cyst
formation and lastly, generalized fibrosis. The changes begin
in utero and eventually will lead to pancreatic insufficiency
(PI), which is manifested in 83% of all CF patients. Clinical
symptoms of PI are abdominal pain, maldigestion and lowered
BMI. Interestingly, 15% of the patients have evidence of
pancreatic damage, but retain sufficient endogenous exocrine
pancreatic function to sustain normal digestion (PS). This
subgroup of patients is at an increased risk of developing
AP. In an elegant study by Ooi et al. (2011) investigated
the association between severity of CFTR genotype and
the risk of developing AP. The involved 277 PS patients
were divided into three groups (severe, moderate-severe and
mild) based on the severity of pancreatic insufficiency. They
showed that patients in the mild group have an increased
risk of pancreatitis compared to moderate-severe and severe
groups.
Acute Pancreatitis
As detailed above, CFTR has a central role in the pancreatic
ductal secretion, whereas impaired function and/or expression
of CFTR in CF leads to exorine pancreatic damage. Taken
these into consideration, it seems reasonable to assume, that
CFTR might have a potential role in the pathogenesis of
AP as well (Hegyi et al., 2016) (Figure 4). Indeed, several
previous studies suggested this relationship. Dimagno et al.
found that the impaired CFTR expression in general knockout
or in F508del mice caused overexpression of proinflammatory
cytokines and increased the severity of cerulein-induced AP
(DiMagno et al., 2005; DiMagno et al., 2010). Recently, our
group analyzed the role of CFTR in the pathogenesis of
alcohol-induced AP. In vivo and in vitro pancreatic fluid and
HCO3− secretion were already decreased in Cftr knockout
mice, which impaired further after treatment with ethanol and
fatty acids (Maleth et al., 2015a). In addition, Cftr knockout
mice developed more severe AP upon ethanol and fatty acid
treatment. The detailed analysis of the underlying mechanism
highlighted that ethanol and fatty acids dose-dependently
reduced the activity and expression of CFTR in pancreatic
ductal cells leading to inhibited epithelial secretion. On the
other hand, ethanol and fatty acids decreased the expression
and plasma membrane density of CFTR due to accelerated
protein turnover at the apical membrane and the protein
folding in the endoplasmic reticulum was damaged as well.
The activity of CFTR was inhibited by sustained elevation
of intracellular Ca2+, decrease in cAMP, depolarization of
mitochondrial membranes, and depletion of ATP caused by
ethanol and fatty acids. The pivotal role of mitochondrial damage
in this process was further highlighted by Judak et al. (2013). The
authors demonstrated that ATP supplementation restored CFTR
activity in pancreatic ductal cells treated with ethanol and fatty
acids.
The other most common form of the disease is biliary
AP, which is caused by choledocholithiasis complicated with
outflow obstruction due to impacted gallstones. Pancreatic
ductal secretion is likely reduced in patients with biliary
AP, as suggested by the decreased intraductal pH, which
correlates with the severity of AP (Takacs et al., 2013).
Under experimental conditions, low concentration of
chenodeoxycholate (CDCA) stimulated, in contrast high
concentrations of CDCA strongly inhibited pancreatic ductal
HCO3− secretion by causing sustained Ca2+ elevation and
severe mitochondrial damage (Venglovecz et al., 2008;
Maleth et al., 2011). Although direct measurements are
missing yet, it is plausible that the consequent intracellular
ATP depletion will affect ATP-dependent transporters like
CFTR.
Chronic Pancreatitis
Chronic pancreatitis (CP) is the progressive inflammation of
the pancreas accompanied by irreversible functional (exocrine
and endocrine pancreatic insufficiency) and structural changes
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FIGURE 4 | The role of CFTR in pancreatic diseases. In cystic fibrosis, acute or chronic pancreatitis the function of CFTR is impaired and/or its expression is
decreased leading to insufficient bicarbonate and fluid secretion and a consequent drop in the intraluminal pH. These changes will decrease the washout of the
digestive enzymes and increase the possibility of mucoprotein plug formation within the pancreatic duct lumen, which further decreases the pancreatic secretion.
These observations suggest that the pancreatic ductal HCO3− and fluid secretion and specifically CFTR channel have a fundamental role in the pathogenesis of
pancreatic diseases.
(ductal dilatation, irregulation, and calcification) (Tattersall et al.,
2008). The incidence of the disease varies between 5 to 12/100,000
(Yadav and Lowenfels, 2013). Moreover on the vast majority of
cases patients suffer from abdominal pain which significantly
decreases their quality of life (Gardner et al., 2010). Current
treatment is limited to enzyme replacement, pain relief and
surgical interventions (pancreas head resection). Ko et al. (2010)
showed earlier that the HCO3− concentration in the pancreatic
juice is decreased in CP (Braganza et al., 2011), in accord
trafficking of CFTR is largely compromised and the protein
is retained at the cytoplasm of pancreatic ductal cells (Ko
et al., 2010). On the other hand Balazs et al. (2018) recently
demonstrated that epithelial fluid secretion defect together with
mucus hypersecretion lead to mucin accumulation in the small
ducts, which can lead to ductal obstruction in CP. These
alterations can reduce intraluminal pH, decrease the washout
of the digestive enzymes and mucoprotein plug formation
within the pancreatic duct lumen (Ko et al., 2012), which
further decreases the pancreatic secretion. These observations
suggest that the pancreatic ductal HCO3− and fluid secretion
and specifically CFTR channel have a fundamental role in the
pathogenesis of CP.
CLOSING REMARKS
In this review we emphasize the effect of CFTR on intracellular
signaling events focusing on the intracellular Ca2+ signaling
and mitochondrial dysfunction. As detailed above both impaired
regulation of the intracellular Ca2+ concentration and the
mitochondrial damage develop due to complex mechanisms that
can further ameliorate cell function and increase cellular damage
complicating the organ damage in CF. These alterations have
been described mainly in airway epithelial cells and we have
very limited information how these mechanisms contribute to
CF-related cell damage in other organs. However, taken into
consideration that CFTR is highly expressed in the polarized
pancreatic ductal cells and plays a pivotal role in the exocrine cell
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secretion, we could assume that these intracellular changes
have a central role in the development of exocrine pancreatic
damage in CF. In a recent case report Kounis et al.
(2018) demonstrated that Ivacaftor treatment (a clinically
used potentiator of CFTR) significantly improved the fecal
elastase-1 level and decrease the number of pancreatic bouts
per month in a patient with heterozygous mutation class
III CFTR gene mutation. This is the first report suggesting
that restoration of CFTR activity might improve exocrine
pancreatic function in CF patients. It would be interesting
to test whether the altered intracellular signaling mechanisms
might be reversed as well. In addition, impaired CFTR
function and expression were observed in AP as well leading
to more severe pancreatic damage. Since toxic intracellular
Ca2+ elevation and mitochondrial damage are hallmarks
of AP, restoration of CFTR activity, or expression could
potentially decrease the cell damage in AP (Mukherjee et al.,
2008; Maleth et al., 2013, 2015b; Maleth and Hegyi, 2016).
Further studies are needed to characterize these pathogenic
steps in the exocrine pancreas, which could lead to better
understanding of the disease pathogenesis and identification
of potential targets that could be used to treat pancreatic
insufficiency in CF.
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